Pennant Group, Inc.

PNTG Nasdaq SEC CIK 1766400
Follow Pennant Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $302.3M +32% vs same quarter last year
Net income $9.6M +58.5% vs same quarter last year
EPS, diluted $0.26 +52.9% vs same quarter last year
Operating cash flow $25.1M +80.4% vs same quarter last year
Revenue by quarter
$188.9M
$209.8M
$219.5M
$229M
$289.3M
$285.4M
$298M
$302.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
$0$250M$500M$750M$1BFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$947.7M$29.6M
FY24$695.2M$22.6M
FY23$544.9M$13.4M
FY22$473.2M$6.6M
FY21$439.7M$2.7M
FY20$391M$15.7M
FY19$338.5M$2.5M
FY18$286.1M$15.7M
FY17$251M$9.9M
FY16--
MarginsShare of revenue
  • Operating margin
  • Net margin
0%2%4%6%8%FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY255.5%3.1%
FY245.5%3.2%
FY234.6%2.5%
FY222.7%1.4%
FY211.1%0.6%
FY204.8%4%
FY191.7%0.8%
FY187.2%5.5%
FY176.1%3.9%
FY16--
Free cash flowOperating cash flow minus capital expenditure
−$40M−$20M$0$20M$40M$60MFY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$36.3M
FY24$30.3M
FY23$25M
FY22−$5.1M
FY21−$24.5M
FY20$43M
FY19$2.8M
FY18$19.7M
FY17$14.1M
FY16-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$5M$10M$15MFY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25--
FY24--
FY23--
FY22-$0
FY21$0$0
FY20$0$65K
FY19$11.6M$0
FY18$0$0
FY17$0-
FY16--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Pennant
  • Healthcare median
−100%−75%−50%−25%0%25%FY17FY19FY21FY23FY25
Show the numbers
YearPennantHealthcare median
FY253.1%−30.6%
FY243.2%−47%
FY232.5%−58%
FY221.4%−80.4%
FY210.6%−71.8%
FY204%−62.2%
FY190.8%−46.2%
FY185.5%−49.6%
FY173.9%−45.9%
FY16-−36%